糖尿病对脑膜瘤术后不良结局的影响
基于美国2012-2014年全国住院样本数据库,纳入7745例脑膜瘤切除术患者,比较糖尿病组(1518例)与非糖尿病组(6227例)的术后结局。多因素回归显示糖尿病与并发症、院内死亡、肺部/神经/泌尿系统并发症及住院时间延长风险升高独立相关。
核心结论
- 糖尿病是脑膜瘤术后并发症的重要相关因素,需采取预防措施优化术后结局。
研究设计与样本
- 回顾性队列研究,使用2012-2014年美国全国住院样本数据库,纳入7745例脑膜瘤切除术患者,分为糖尿病组1518例和非糖尿病组6227例。
- 采用Fisher精确检验和方差分析比较组间特征,Logistic回归分析糖尿病对不良结局的独立效应。
- 住院时间延长定义为超过样本第90百分位数。
主要发现
- 糖尿病组平均住院时间8.15天,非糖尿病组6.04天(P<0.001);糖尿病组总费用139462.66美元,非糖尿病组123250.71美元(P<0.001)。
- 糖尿病组术后并发症风险升高(OR 1.442,95%CI 1.255-1.656,P<0.001),院内死亡风险升高(OR 1.672,95%CI 1.034-2.705,P=0.036)。
- 糖尿病组肺部并发症风险升高(OR 1.501,95%CI 1.209-1.864,P<0.001),神经并发症风险升高(OR 1.690,95%CI 1.383-2.065,P<0.001),泌尿/肾脏并发症风险升高(OR 2.618,95%CI 1.933-3.545,P<0.001)。
- 糖尿病组住院时间延长风险升高(OR 1.694,95%CI 1.389-2.065,P<0.001)。
临床怎么用
- 对脑膜瘤手术患者应评估糖尿病状态,并将其纳入术后并发症风险分层。
- 对糖尿病患者需加强围手术期管理,以降低并发症、死亡和住院时间延长的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to investigate the association between diabetes mellitus and incidence of adverse outcomes in patients who underwent meningioma surgery. METHODS: The 2012-2014 National Inpatient Sample database was used. Prolonged length of stay was indicated by values greater than the 90th percentile of the sample. The Fisher exact test and analysis of variance were used to compare demographics, hospital characteristics, comorbidity, and complications among race cohorts. Logistic regression was used to analyze the independent effect of diabetes on adverse outcomes. RESULTS: After selecting for patients with primary diagnosis of meningioma who underwent a resection procedure, 7745 individuals were identified and divided into diabetic (n = 1518) and nondiabetic (n = 6227) cohorts. Demographics, hospital characteristics, and comorbidities were significantly different among the 2 cohorts. Average length of stay was longer in diabetic patients (8.15 vs. 6.04 days, P < 0.001), and total charges were higher in diabetic patients ($139,462.66 vs. $123,250.71, P < 0.001). Multivariate regression indicated diabetic patients have higher odds of experiencing a complication (odds ratio [OR] 1.442, 95% confidence interval [CI] 1.255-1.656, P < 0.001) and in-hospital mortality (OR 1.672, 95% CI 1.034-2.705, P = 0.036) after meningioma surgery. Analysis of individual postoperative complications revealed that diabetic patients experienced increased odds of pulmonary (OR 1.501, 95% CI 1.209-1.864, P < 0.001), neurologic (OR 1.690, 95% CI 1.383-2.065, P < 0.001), and urinary/renal complications (OR 2.618, 95% CI 1.933-3.545, P < 0.001). In addition, diabetic patients were more likely to have a prolonged length of stay (OR 1.694, 95% CI 1.389-2.065, P < 0.001). CONCLUSIONS: Diabetes is an important factor associated with complications after meningioma surgery. Preventative measures must be taken to optimize postoperative outcomes in these patients.
引用
- Randhawa KS, Choi CB, Shah AD, et al. Impact of Diabetes Mellitus on Adverse Outcomes After Meningioma Surgery. World Neurosurg. 2021. PMID: 34062298. doi:10.1016/j.wneu.2021.05.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。